Cannabinoids in Chronic Pain and Mood Disorders-Focus on Dronabinol
Target Audience
This activity provides continuing education for pharmacists and pharmacy technicians. A certificate of attendance is available for other attendees.
Learning Objectives
- Understand the pathophysiology of cannabinoid analgesia.
- Discuss the pharmacological mechanisms of cannabinoid medications.
- Review empirical studies of cannabinoid pharmacotherapy in treatment of chronic pain and headache.
- State the DEA Classification of Controlled Substances.
- Identify major risks of cannabinoid pharmacotherapy.
- Compare key differences between dronabinol and cannabis.
Disclosure
Michael G. Williams, PharmD, CPP. Presenter has no financial or non-financial relationships to disclose.
DHA J-7 staff, Planning Committee Members and reviewers have no financial or non-financial interest to disclose. All faculty members have no financial or non-financial interest to disclose.
Available Credit
- 1.00 AAPADHA J-7 CEPO has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 hours of AAPA Category 1 CME credits. Physician assistants should only claim credit commensurate with the extent of their participation.
- 1.00 ACCME Non-Physician CME CreditDHA J-7 CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education. ACCME Non-Physician CME Credit providers will be provided a certificate of participation for educational activities certified for AMA PRA Category 1 Credit™. ACCME Non-Physician CME Credit providers may receive a maximum of 1.00 hours for completing this Course activity.
- 1.00 ACPE PharmacistUAN JA4008136-0000-22-290-L04-P
No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacists. This knowledge based activity will provide a maximum of 1.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity. - 1.00 ACPE Pharmacy technicianUAN JA4008136-0000-22-290-L04-T
No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacy Technicians. This knowledge based activity will provide a maximum of 1.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity. - 1.00 Physicians (ACCME)
DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
DHA, J-7, CEPO designated this Course for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 ANCCThe DHA, J-7, CEPO is accredited by the Joint Accreditation/ Interprofessional Continuing Education (IPCE) to provide this Continuing Nursing Education Course for a maximum of 1.00 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
- 1.00 Certificate of Attendance
- 1.00 Interprofessional Continuing Education (IPCE)
In support of improving patient care, the DHA, J-7, CEPO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. This activity was planned by and for the health care team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.